miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma (Q39255366)

10 September 2017

miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma (English)

1 reference

10 September 2017

1 reference

Gang Shen

1

1 reference

10 September 2017

Hongyun Jia

2

1 reference

10 September 2017

Qiang Tai

3

1 reference

10 September 2017

Yanhao Li

4

1 reference

10 September 2017

Deji Chen

5

1 reference

10 September 2017

language of work or name

English

0 references

publication date

20 October 2012

1 reference

10 September 2017

1 reference

10 September 2017

34

1 reference

10 September 2017

1

1 reference

10 September 2017

211-219

1 reference

Targeted therapy for hepatocellular carcinoma

10 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Systemic therapies in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Genetics of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Beta-catenin: a key mediator of Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Wnt/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Wnts as ligands: processing, secretion and reception

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Proximal events in Wnt signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Wnt/beta-catenin signaling: components, mechanisms, and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Conserved functions of the pRB and E2F families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Pocket proteins and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Circulating microRNAs in plasma of patients with gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Cyclins and cell cycle checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

The subcellular destinations of APC proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Dysregulation of growth factor signaling in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Wnt/Frizzled signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

A microRNA polycistron as a potential human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

Epidemiology of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS320

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGS320

1 reference

10 September 2017

1 reference